ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively
20 December 2022 - 10:38AM
Dow Jones News
By Denny Jacob
International stocks trading in New York closed mixed on
Monday.
The S&P/BNY Mellon index of American depositary receipts
ticked down 0.1% to 139.76. The European index edged down 0.3% to
135.84. The Asian index retreated 0.1% to 161.34. The Latin
American index rose 1.2% to 174.86, while the emerging-markets
index gained 0.2% to 270.84.
AstraZeneca PLC was among those whose ADRs traded actively.
The pharmaceutical giant edged down 0.7% following news that its
Forxiga drug has been recommended for approval in the European
Union for certain types of heart failure, while its Imfinzi and
Imjudo combinations have been recommended for marketing
authorization in the EU for advanced liver and lung cancer.
Clinical-stage biopharmaceutical company atai Life Sciences
slipped 4.5% following news that it initiated its Phase 2b
proof-of-concept clinical trial for RL-007 for cognitive impairment
associated with schizophrenia.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
December 19, 2022 18:23 ET (23:23 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Nov 2023 to Dec 2023
ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Dec 2022 to Dec 2023